Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
120KRW
1.66 BKRW
196.35 BKRW
12.16 M
About SAMIL PHARM
Sector
Headquarters
Seoul
Employees (FY)
568
Website
Founded
1947
ISIN
KR7000520007
FIGI
BBG000BDQNM5
SAMIL PHARMACEUTICAL Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include CNS Drugs, Ophthalmic Drugs, Respiratory Drugs, Genito-urinary Drugs, Antibiotics Chemotherapeutics, Circulatory Drugs, Gastro-Intestinal Drugs, Agents for Diabetes Mellitus, Hormones, Metabolic Drugs, Disinfectants, Amino Acids, Dental Preparations, Antipyretic, Allergy Drugs, Antihistamines, Analgesic, and Anti-inflammatory Agents. The company was founded on October 7, 1947 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 000520 is 9300 KRW — it has increased by 0.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMIL PHARM stocks are traded under the ticker 000520.
SAMIL PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
000520 stock is 1.97% volatile and has beta coefficient of −0.13. Check out the list of the most volatile stocks — is SAMIL PHARM there?
Yes, you can track SAMIL PHARM financials in yearly and quarterly reports right on TradingView.
000520 stock has fallen by 4.81% compared to the previous week, the month change is a 18.13% fall, over the last year SAMIL PHARM has showed a 15.82% increase.
000520 net income for the last quarter is 894.11 M KRW, while the quarter before that showed −657.05 M KRW of net income which accounts for 236.08% change. Track more SAMIL PHARM financial stats to get the full picture.
Today SAMIL PHARM has the market capitalization of 178.04 B, it has decreased by 5.98% over the last week.
Like other stocks, 000520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMIL PHARM stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 568.00 employees. See our rating of the largest employees — is SAMIL PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMIL PHARM technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMIL PHARM stock shows the buy signal. See more of SAMIL PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMIL PHARM EBITDA is 11.82 B KRW, and current EBITDA margin is 6.02%. See more stats in SAMIL PHARM financial statements.